This page contains affiliate links. We may earn a commission if you sign up through them, at no cost to you. All recommendations are independent.

Embody's $400-CPA Pricing Breakdown: Injectable Sema Cost Structure

Embody has positioned as a leading compounded-injectable-semaglutide-only program. The $400 affiliate CPA tier reflects a specific patient economic model. Here's the breakdown of what patients actually pay across the titration schedule.

The Product Focus

Embody's positioning is deliberate: injectable semaglutide only. Not oral. Not tirzepatide. Not gum format. This single-molecule, single-route focus lets the program optimize its pharmacy supply chain, prescriber protocols, and patient education around one product — which shows up in operational consistency at scale.

For patients who want compounded injectable semaglutide specifically, Embody's focus is a feature. For patients who want tirzepatide or oral formats, it's not the right platform.

Embody

Injectable semaglutide (verify current tier)

Lead compounded-injectable option with a $400 CPA tier.

  • Injectable semaglutide only
  • Standard titration schedule
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Titration Cost Progression

Compounded semaglutide programs typically structure pricing by dose tier rather than by flat rate. Embody's structure follows this pattern: low starting-dose tier for weeks 1-4, standard mid-dose tier for weeks 5-16, and maintenance-dose tier for weeks 17+. Actual pricing at each tier is set in the current program terms and should be verified at intake.

Total first-quarter cost typically runs lower than annualized rate because patients spend time at lower-priced titration tiers. Annual cost is closer to maintenance-tier pricing since most patients spend most of the year at maintenance.

What's Included

Standard Embody-tier programs typically include: prescriber consultation, initial prescription, monthly medication supply, care team access for questions during titration, and shipping. What's typically not included: labs (patients bring their own or add via the platform), ongoing dietitian coaching (available as add-on at some programs), and any add-on wellness services.

Embody

Injectable semaglutide (verify current tier)

Lead compounded-injectable option with a $400 CPA tier.

  • Injectable semaglutide only
  • Standard titration schedule
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

The $400 CPA Signal

Affiliate CPA (cost per acquisition) at the $400 tier tells you something about the program's unit economics: the program can profitably acquire a patient for that marketing cost, which requires either higher lifetime value per patient, longer average patient retention, or both. Higher CPA programs typically have more sophisticated retention and better care team quality — otherwise the numbers don't work.

How to Compare

When comparing Embody to lower-priced compounded programs, look at: total 12-month cost including all fees; maintenance-dose pricing (not just intro); refund and cancellation terms; and care team availability. Cheapest program often isn't lowest total spend once you account for retention friction and support quality.

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

SHED

Starts lower, $399/mo at 7.5mg+

Note: SHED's price jumps to $399/mo at 7.5mg or higher.

  • Lower entry pricing
  • Price jump at 7.5mg+
  • Compounded semaglutide + tirzepatide
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Telos Rx

Weight-loss LP1 tirzepatide

Compounded tirzepatide via direct pharmacy program.

  • Compounded tirzepatide focus
  • Direct-link intake format
  • Verify current pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Where to Start

Embody

Injectable semaglutide (verify current tier)

Lead compounded-injectable option with a $400 CPA tier.

  • Injectable semaglutide only
  • Standard titration schedule
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder — compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing